Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Maria, Francesca Alvisi"'
Autor:
Federica Guffanti, Ilaria Mengoli, Maria Francesca Alvisi, Giulia Dellavedova, Raffaella Giavazzi, Robert Fruscio, Eliana Rulli, Giovanna Damia
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Standard therapy for high-grade ovarian carcinoma includes surgery followed by platinum-based chemotherapy and poly-ADP ribose polymerase inhibitors (PARPis). Deficiency in homologous recombination repair (HRD) characterizes almost half of high-grade
Externí odkaz:
https://doaj.org/article/2127c2040db746258480908726af6174
Autor:
Maria Francesca Alvisi, Paola Dordoni, Tiziana Rancati, Barbara Avuzzi, Nicola Nicolai, Fabio Badenchini, Letizia De Luca, Tiziana Magnani, Cristina Marenghi, Julia Menichetti, Villa Silvia, Zollo Fabiana, Salvioni Roberto, Valdagni Riccardo, Bellardita Lara, the Prostate Cancer Multidisciplinary Clinic Working Group
Publikováno v:
Frontiers in Psychology, Vol 11 (2020)
BackgroundThe psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e
Externí odkaz:
https://doaj.org/article/c0e8f0b5761c4d57bd189b7e86453c4c
Autor:
Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, Maria Ornella Nicoletto, Germana Tognon, Alessandra Bologna, Andrea Alberto Lissoni, Andrea DeCensi, Mariateresa Lapresa, Rosanna Mancari, Innocenza Palaia, Giulia Tasca, Francesca Tettamanzi, Maria Francesca Alvisi, Eliana Rulli, Davide Poli, Luciano Carlucci, Valter Torri, Roldano Fossati, Elena Biagioli
Background: Previous findings showed that cediranib-olaparib increased PFS in women with recurrent platinum-sensitive ovarian cancer compared to olaparib alone. Methods: BAROCCO trial randomized 123 patients: 80 mg/m2 paclitaxel weekly up to 24 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50894eb2b17531be40c0f3ed8a7a185
http://hdl.handle.net/11573/1643684
http://hdl.handle.net/11573/1643684
Autor:
Violeta Serra, Giovanna Damia, Alessia Anastasia, Francesca Ricci, A Degasperi, Raffaella Giavazzi, Eliana Rulli, Federica Guffanti, Robert Fruscio, Maria Francesca Alvisi, Serena Nik-Zainal, Michela Lupia, Michela Chiappa, M.R. Bani, A Llop-Guevara
Publikováno v:
Br J Cancer
Background: The search for biomarkers to evaluate ovarian cancer (OC) homologous recombination (HR) function and predict the response to therapy is an urgent clinical need to improve the selection of patients who could benefit from platinum- and olap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99978061d25faa64817ef6b7310b143b
https://zenodo.org/record/5816653
https://zenodo.org/record/5816653
Autor:
Davide Martini, Roberto Tessari, Alessandro Nobili, Elena Pomari, Zeno Bisoffi, Irene De Simone, Marco Gobbi, Spinello Antinori, Maria Carla Roncaglioni, Caterina Campoli, Fabio Chesini, Maria Luisa Ojeda Fernandez, Michela Deiana, Dora Buonfrate, Maria Francesca Alvisi, Eliana Rulli, Gianluigi Lunardi, Giacomo Casalini
Publikováno v:
International Journal of Antimicrobial Agents
Background: High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. Aim of this study was to assess safety and efficacy of high-dose ivermectin in reducing viral load in individuals with initial SARS-CoV-2 infec
Autor:
Marina Chiara Garassino, Amanda Psyrri, Michele Milella, Helena Linardou, Fabiana Letizia Cecere, Maria Francesca Alvisi, Eliana Rulli, Anna Cecilia Bettini, Gloriana Ndembe, Marcella De Maglie, Samuel S. Murray, Pierpaolo Romanelli, Massimo Broggini, Giuseppe Lo Russo, Mirko Marabese, Monica Ganzinelli, Alessandra Fabbri, Elisa Caiola
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2438, p 2438 (2020)
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2438, p 2438 (2020)
Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase &beta
expression could
expression could
Autor:
Maria Francesca, Alvisi, Monica, Ganzinelli, Helena, Linardou, Elisa, Caiola, Giuseppe, Lo Russo, Fabiana Letizia, Cecere, Anna Cecilia, Bettini, Amanda, Psyrri, Michele, Milella, Eliana, Rulli, Alessandra, Fabbri, Marcella, De Maglie, Pierpaolo, Romanelli, Samuel, Murray, Gloriana, Ndembe, Massimo, Broggini, Marina Chiara, Garassino, Mirko, Marabese
Publikováno v:
Journal of Clinical Medicine
Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase β expression could help ide
Autor:
Flavio Capriolia, Eliana Rulli, Matilde De Luca, Georgia Lattanzi, Jens Geginat, Marina Coletta, Federica Facciotti, Massimo Fantini, Moira Paroni, Sergio Abrignani, Maria Francesca Alvisi, Stefano Mazza, Maurizio Vecchi, Francesco Strati
Publikováno v:
Journal of Crohn's and Colitis. 16:1010-1010
Autor:
Lara Bellardita, Paola Dordoni, Maria Francesca Alvisi, Tiziana Magnani, Letizia De Luca, Riccardo Valdagni, Julia Menichetti, Fabio Badenchini, Teresa Di Florio, C. Marenghi, Tiziana Rancati
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(2)
To investigate whether prostate cancer (PCa) patients’ coping strategies (i.e., fighting spirit, anxious preoccupation, fatalism, helplessness/hopelessness, and avoidance) significantly change during the first 3-year follow-up period of active surv
Autor:
S. Morlino, Maurizio Colecchia, A. Tesone, Maria Francesca Alvisi, Tiziana Magnani, Roberto Salvioni, Sergio Villa, Lara Bellardita, Tullio Torelli, Riccardo Valdagni, Silvia Stagni, Barbara Avuzzi, Federica Palorini, Tiziana Rancati, C. Marenghi, Nicola Nicolai, Fabio Badenchini, Antonella Messina, E. Tulli Baldoin, Mario Catanzaro, Nice Bedini
Publikováno v:
European Urology Supplements. 16:e1390-e1392